C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2002
10/17/2002	US20020150993 Nucleotide sequences coding polypeptide for use in the treament of apoptosis, inflammatory or autoimmune diseases
10/17/2002	US20020150988 Nucleotide sequences coding polypeptide for use in the forensic analysis and diagnosis and treatment of genetic disorders
10/17/2002	US20020150986 Extracellular matrix signalling molecules
10/17/2002	US20020150981 Methods for producing highly phosphorylated lysosomal hydrolases
10/17/2002	US20020150980 Nucleotide sequences coding protein for use in the treatment of asthma, parkinson's, heart, hypotension, osteporosis and urogenital disorders
10/17/2002	US20020150977 Nucleotide sequences coding protein for use in the diagnosis, treatment and prevention of autoimmune, cell proliferative and inflammatory diseases
10/17/2002	US20020150976 Nucleotide sequences coding polypeptide for use in the treatment of arthritis and bone disorders
10/17/2002	US20020150963 Map
10/17/2002	US20020150948 Antibody PTI-HS7 for treatment of alzheimer's disease and other amyloidoses and parkinson's disease
10/17/2002	US20020150914 Recombinant antibodies from a phage display library, directed against a peptide-MHC complex
10/17/2002	US20020150902 Polymorphic loci that differentiate escherichia coli 0157:H7 from other strains
10/17/2002	US20020150889 Peptide for use in the detection of herpes virus infections
10/17/2002	US20020150888 Methods of screening for modulators of HIV infection
10/17/2002	US20020150882 Detecting preferential cd antigen in sample; obtain fluid sample, incubate with preferential antibody, detect signal
10/17/2002	US20020150591 Amplification nucleic acids
10/17/2002	US20020150587 Immunological polypeptides; vaccine against gramnegative bacteria
10/17/2002	US20020150586 Novel amino acid sequences, DNA encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof
10/17/2002	US20020150580 Administering genetic engineered antibody; binding to antigen; rheumatic diseases, skin disorders, autoimmune disease
10/17/2002	US20020150577 Transforming growth factor; transgenic animal; increas ratios of muscle mass
10/17/2002	US20020150576 Humanized anti-CCR2 antibodies and methods of use therefor
10/17/2002	US20020150575 Method to suppress appetite and reduce weight gain
10/17/2002	US20020150574 Cancer diagnosis, therapy; Dna vaccine
10/17/2002	US20020150573 Induce cell elimination using antibodies; antitumor agents
10/17/2002	US20020150572 Methods and compositions for the treatment of psoriasis
10/17/2002	US20020150571 Antibodies specific for native PrPSc
10/17/2002	US20020150570 Anti-CCR2 antibodies and methods of use therefor
10/17/2002	US20020150569 Using monoclonal antibodies
10/17/2002	US20020150567 Novel grb2 associating polypeptides and nucleic acids encoding therefor
10/17/2002	US20020150559 Binding of human antigens
10/17/2002	US20020150551 Protease surface treatment
10/17/2002	US20020150534 Tumor necrosis factor-gamma
10/17/2002	DE10201458A1 New proteins involved in isoprenoid biosynthesis, useful in screening for inhibitors, also new intermediates, potential therapeutic agents, nucleic acids and antibodies
10/17/2002	CA2480464A1 Anti-idiotypic antibody and its use in diagnosis and therapy of hepatitis c virus related diseases
10/17/2002	CA2446886A1 Method for detecting chronic dementia diseases, and corresponding peptides and detection reagents
10/17/2002	CA2443813A1 Method for identification of proteins from intracellular bacteria
10/17/2002	CA2443694A1 Anti-cd19 immunotoxins
10/17/2002	CA2443405A1 Use of cd25 binding molecules in steroid-resistant patients
10/17/2002	CA2443372A1 Immunotherapeutic combinations for the treatment of tumors that over-express gangliosides
10/17/2002	CA2443334A1 Protein modification and maintenance molecules
10/17/2002	CA2443332A1 .alpha..nu..beta.3 integrin-binding polypeptide monobodies and their use
10/17/2002	CA2443330A1 Anti-osteopontin antibody and use thereof
10/17/2002	CA2443323A1 Nucleic acid vaccines for prevention of flavivirus infection
10/17/2002	CA2443303A1 Method for preparing and selecting antibodies
10/17/2002	CA2443294A1 Remedies for infant chronic arthritis-relating diseases
10/17/2002	CA2443293A1 Production of polyclonal monospecific antibodies against upar variants del4, del5 and del4+5, and the use thereof for diagnostic and therapeutical purposes
10/17/2002	CA2442839A1 Production and use of novel peptide-based agents for use with bi-specific antibodies
10/17/2002	CA2442817A1 Implantation serine proteinases
10/17/2002	CA2442739A1 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
10/17/2002	CA2442685A1 Estrogen receptor-related receptor alpha (err.alpha.) and cartilage formation
10/17/2002	CA2442386A1 Epitope sequences
10/17/2002	CA2441499A1 Method for producing a vaccine
10/17/2002	CA2435528A1 Novel polypeptides and nucleic acids encoded thereby
10/17/2002	CA2429376A1 Mitogenic oxygenase regulators
10/16/2002	EP1249492A2 Antibodies against an adrenergic receptor
10/16/2002	EP1249491A2 Human very long chain acyl-CoA synthase (VLCAS)-like protein and nucleic acids encoding it
10/16/2002	EP1249456A1 Novel peptide and screening method by using the same
10/16/2002	EP1248843A2 Nphs2 gene involved in the cortico-resistant neprhotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses
10/16/2002	EP1248841A2 Genes differentially expressed in breast cancer
10/16/2002	EP1248840A2 Circularly permutated, interaction-activated proteins
10/16/2002	EP1248804A2 Recombinant antibodies to human interleukin-1 beta
10/16/2002	EP1248803A2 Nogo receptor-mediated blockade of axonal growth
10/16/2002	EP1248802A2 Soluble ctla4 mutant molecules and uses thereof
10/16/2002	EP1248801A1 Human polynucleotides, polypeptides, and antibodies
10/16/2002	EP1248800A2 Compositions and methods for therapy and diagnosis of breast cancer
10/16/2002	EP1248799A2 Chemically modified hiv envelope glycoprotein
10/16/2002	EP1248644A1 Method for enhancing the presentation of exogenous antigen by human antigen-presenting cells and opsonized micro particle complexes for applying this
10/16/2002	EP1248641A1 Use of emap ii receptor antagonist composition for treating pulmonary hypertension
10/16/2002	EP1248552A1 Pp14 fusion proteins and methods for making and using the same
10/16/2002	EP1248516A2 38 human secreted proteins
10/16/2002	EP1137935A4 Detection of preharvest sprouting in cereal grains
10/16/2002	EP0973794B1 Netrin receptors
10/16/2002	EP0672128B1 Stem cell proliferation factor
10/16/2002	EP0639225B1 New polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology
10/16/2002	CN1375006A Novel compound
10/16/2002	CN1374870A Treatment of intermediate-and high-grade non-Hodgkins lymphoma with anti-CD20 antibody
10/16/2002	CN1374869A Use of CASB 616 polypeptides and polynucleotides for cancer treatment
10/16/2002	CN1374405A Relative protein coding sequence, preparation and use of human adenylate cyclase
10/16/2002	CN1092712C Process for producing human C36/C46 receptor (CR1) polypeptide
10/15/2002	US6465655 Quaternary pyridinium salt analogs useful as ligands in an immunoassay for detecting osteoporosis
10/15/2002	US6465621 Polypeptides and polynucleotides of the gtp-binding protein family
10/15/2002	US6465434 Methods and compositions for the inhibition of cancer metastasis mediated by endothelial adhesion molecules
10/15/2002	US6465423 Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
10/15/2002	US6465239 Genetically engineered chromosomes in germ cells; high protein and muscle foods
10/15/2002	US6465204 Amidase
10/15/2002	US6465194 Monoclonal antibodies to 4,4′-dinitrocarbanilide and a method for analyzing for the drug nicarbazin
10/15/2002	US6465181 Reagents and methods useful for detecting diseases of the prostate
10/15/2002	US6465173 Diagnosis, therapy aids
10/15/2002	US6465172 HIV immunogenic complexes comprising GP120 covalently bound to CD4 or concanavalin A
10/15/2002	US6464974 Immunosuppressant target proteins
10/10/2002	WO2002079781A1 Methods of detecting early renal disease in animals
10/10/2002	WO2002079517A1 Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor
10/10/2002	WO2002079492A2 Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators
10/10/2002	WO2002079448A2 G-protein coupled receptors
10/10/2002	WO2002079447A2 Avian lysozyme promoter
10/10/2002	WO2002079441A2 Secreted proteins
10/10/2002	WO2002079429A2 Anti-muc-1 single chain antibodies for tumor targeting
10/10/2002	WO2002079415A2 Reducing the immunogenicity of fusion proteins
10/10/2002	WO2002079404A2 Cytoskeleton-associated proteins
10/10/2002	WO2002079396A2 Biological carriers for induction of immune responses
10/10/2002	WO2002079377A2 Antibodies that immunospecifically bind to trail receptors

1 ... 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 ... 1494